Related Experiment Video
Updated: Dec 2, 2025

Establishing a Competing Risk Regression Nomogram Model for Survival Data
Published on: October 23, 2020
Trends in COVID-19 Risk-Adjusted Mortality Rates
Leora I Horwitz1,2,3, Simon A Jones1,2, Robert J Cerfolio4
1Center for Healthcare Innovation and Delivery Science, NYU Langone Health, New York, New York.
Insights
COVID-19 (coronavirus disease 2019) mortality has decreased, even when accounting for patient demographics and clinical factors. This study suggests improved outcomes in a New York health system from March to August 2020.
Area of Science:
- Infectious Diseases
- Epidemiology
- Critical Care Medicine
Background:
- Early phases of the COVID-19 pandemic were associated with high in-hospital mortality rates.
- Recent observations suggest a decline in COVID-19 mortality, prompting investigation into contributing factors.
- Changes in patient demographics, including age and comorbidities, may influence observed mortality trends.
Purpose of the Study:
- To investigate the association between changing patient demographics and hospital mortality during the COVID-19 pandemic.
- To determine if the decrease in COVID-19 mortality rates is attributable to improved treatments or shifts in patient characteristics.
- To analyze in-hospital mortality trends adjusted for demographic and clinical factors within an academic health system.
Main Methods:
- Retrospective analysis of 5,121 hospitalizations for COVID-19 from March to August 2020 across three hospitals.
- In-hospital mortality or discharge to hospice was the primary outcome measure.
- Statistical adjustment for demographic factors, comorbidities, admission vital signs, and laboratory results was performed.
Main Results:
- Adjusted in-hospital mortality for COVID-19 decreased significantly from 25.6% in March to 7.6% in August 2020.
- The standardized mortality ratio declined from 1.26 in March to 0.38 in August, indicating a substantial reduction in observed versus expected deaths.
- The average probability of death decreased by 18.2 percentage points from March to August, after accounting for patient characteristics.
Conclusions:
- COVID-19 hospital mortality has demonstrably decreased within this academic health system.
- The observed reduction in mortality persists even after adjusting for changes in patient demographics and clinical profiles.
- These findings suggest a genuine improvement in COVID-19 outcomes over time, independent of patient population shifts.
Abstract:
Early reports showed high mortality from coronavirus disease 2019 (COVID-19). Mortality rates have recently been lower, raising hope that treatments have improved. However, patients are also now younger, with fewer comorbidities. We explored whether hospital mortality was associated with changing demographics at a 3-hospital academic health system in New York. We examined in-hospital mortality or discharge to hospice from March through August 2020, adjusted for demographic and clinical factors, including comorbidities, admission vital signs, and laboratory results. Among 5,121 hospitalizations, adjusted mortality dropped from 25.6% (95% CI, 23.2-28.1) in March to 7.6% (95% CI, 2.5-17.8) in August. The standardized mortality ratio dropped from 1.26 (95% CI, 1.15-1.39) in March to 0.38 (95% CI, 0.12-0.88) in August, at which time the average probability of death (average marginal effect) was 18.2 percentage points lower than in March. Data from one health system suggest that mortality from COVID-19 is decreasing even after accounting for patient characteristics.
More Related Videos
Related Concept Videos
Relative Risk
Factors Affecting the Risk of Infection
The integrity and count of the white blood cells help the body resist pathogens and fight infection. When impaired, it reduces the body's resistance to pathogens. The acidic pH levels of the gastrointestinal, genitourinary tracts, and skin...
Actuarial Approach
Consider the example of a high-risk surgical procedure with significant early-stage mortality. A two-year clinical study is conducted,...
Bias in Epidemiological Studies
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
Factors Affecting Illness
For instance, risk factors are connected to illness,...

